HOME PRODUCTS COMPANY CONTACT FAQ

Research Dictionary Pharma

Sign Up FREE or Login

Amoebic gill disease

Also Known As:

Amoebic gill infection; Neoparamoeba perurans infection

Networked: 32 relevant articles (4 outcomes, 7 trials/studies)

Relationship Network

Disease Context: Research Results

Infections: 526564
- Parasitic Diseases: 4870
  - Protozoan Infections: 282
    - Amebiasis: 1455
      - Amoebic gill disease: 32
Animal Diseases: 416
- Fish Diseases: 134
  - Amoebic gill disease: 32

Related Diseases

1.	Parasitic Diseases (Parasitic Disease)
2.	Infections

Experts

1.	Nowak, Barbara F: 6 articles (03/2021 - 11/2006)
2.	Nowak, B F: 4 articles (11/2012 - 01/2003)
3.	Powell, Mark D: 4 articles (09/2010 - 01/2005)
4.	MacCarthy, Eugene: 2 articles (01/2021 - 12/2018)
5.	O'Connor, Ian: 2 articles (01/2021 - 12/2018)
6.	Slinger, Joel: 2 articles (08/2020 - 01/2020)
7.	Wynne, James W: 2 articles (08/2020 - 01/2020)
8.	Bron, James E: 2 articles (03/2020 - 06/2019)
9.	Cook, Mathew T: 2 articles (12/2019 - 06/2014)
10.	Bridle, Andrew R: 2 articles (11/2019 - 11/2006)

Drugs and Biologics

Drugs and Important Biological Agents (IBA) related to Amoebic gill disease:

1.	Bithionol (Bitin)IBA 05/01/2009 - "This study examined the efficacy of bithionol as a prophylactic or therapeutic oral treatment for Atlantic salmon (AS), Salmo salar, affected by amoebic gill disease (AGD). " 03/31/2007 - "This study examined the toxicity of bithionol to Atlantic salmon Salmo salar and rainbow trout Oncorhynchus mykiss in fresh- and seawater and the efficacy of bithionol as a 1h seawater bath treatment for amoebic gill disease (AGD). " 03/31/2007 - "Evaluation of bithionol as a bath treatment for amoebic gill disease caused by Neoparamoeba spp." 05/01/2009 - "Further development of bithionol therapy as a treatment for amoebic gill disease in Atlantic salmon, Salmo salar L." 09/17/2010 - "The objective of the present study was to evaluate the in vitro toxicity of bithionol and bithionol sulphoxide to Neoparamoeba spp., the causative agent of amoebic gill disease (AGD). "
2.	VaccinesIBA 03/30/2021 - "Experimental Challenge Models and In Vitro Models to Investigate Efficacy of Treatments and Vaccines against Amoebic Gill Disease."
3.	AntibodiesIBA 01/01/2004 - "It appears unlikely that these antibodies elicit any specific protection against amoebic gill disease (AGD) as fish with demonstrable activities have been affected by AGD. "
4.	OligodeoxyribonucleotidesIBA 01/01/2003 - "Immunostimulatory CpG oligodeoxynucleotides increase resistance against amoebic gill disease in Atlantic salmon, Salmo salar L." 06/01/2005 - "Based on our previous work that showed potent immunostimulatory CpG motif-containing oligodeoxynucleotides increased resistance to amoebic gill disease (AGD), the present study investigated the immunostimulatory effects of three commercial beta-glucan-containing feeds and their ability to increase resistance to AGD. "
5.	Glycoproteins (Glycoprotein)IBA 01/01/2005 - "This study reports on the mucus viscosity and glycoprotein biochemistry of Atlantic salmon (Salmo salar L.), brown trout (Salmo trutta L.) and rainbow trout (Oncorhynchus mykiss Walbaum) in freshwater and seawater, both naive to and affected by amoebic gill disease (AGD). " 12/01/2010 - "Characterisation of an immunodominant, high molecular weight glycoprotein on the surface of infectious Neoparamoeba spp., causative agent of amoebic gill disease (AGD) in Atlantic salmon." 01/01/2005 - "The viscosity and glycoprotein biochemistry of salmonid mucus varies with species, salinity and the presence of amoebic gill disease."
6.	beta-GlucansIBA 06/01/2005 - "The effect of beta-glucan administration on macrophage respiratory burst activity and Atlantic salmon, Salmo salar L., challenged with amoebic gill disease--evidence of inherent resistance." 06/01/2005 - "Based on our previous work that showed potent immunostimulatory CpG motif-containing oligodeoxynucleotides increased resistance to amoebic gill disease (AGD), the present study investigated the immunostimulatory effects of three commercial beta-glucan-containing feeds and their ability to increase resistance to AGD. "
7.	Recombinant ProteinsIBA 06/01/2014 - "This study investigated the use of a recombinant protein of Neoparamoeba perurans, the causative agent of Amoebic gill disease (AGD), as an immunogen to generate systemic and mucosal antibody responses against the parasite. "
8.	Genetic Markers (Genetic Marker)IBA 12/19/2019 - "The present study explored the use of 2 common genetic markers, the mitochondrial cytochrome oxidase I (COI) and the ribosomal internal transcribed spacer (ITS) to infer the relationship between geographically distant isolates of the protozoan gill parasite Neoparamoeba perurans, the agent responsible for amoebic gill disease in farmed Atlantic salmon worldwide. "
9.	Electron Transport Complex IV (Cytochrome c Oxidase)IBA 12/19/2019 - "The present study explored the use of 2 common genetic markers, the mitochondrial cytochrome oxidase I (COI) and the ribosomal internal transcribed spacer (ITS) to infer the relationship between geographically distant isolates of the protozoan gill parasite Neoparamoeba perurans, the agent responsible for amoebic gill disease in farmed Atlantic salmon worldwide. "
10.	sulfoxideIBA 09/17/2010 - "The objective of the present study was to evaluate the in vitro toxicity of bithionol and bithionol sulphoxide to Neoparamoeba spp., the causative agent of amoebic gill disease (AGD). " 09/17/2010 - "In vitro toxicity of bithionol and bithionol sulphoxide to Neoparamoeba spp., the causative agent of amoebic gill disease (AGD)."

Therapies and Procedures

1.	Therapeutics 05/01/2009 - "Further development of bithionol therapy as a treatment for amoebic gill disease in Atlantic salmon, Salmo salar L."
2.	Transcutaneous Electric Nerve Stimulation (TENS) 01/01/2018 - "For example, amoebic gill disease ravages farmed salmonids worldwide, causing tens of millions of dollars in losses annually. "